IVERIC bio (NASDAQ:ISEE) reported Q1 EPS of ($0.29), in-line with the analyst estimate of ($0.29). Revenue for the quarter came in at $0 , versus $0 reported last year.
IVERIC bio (NASDAQ:ISEE) reported Q1 EPS of ($0.29), in-line with the analyst estimate of ($0.29). Revenue for the quarter came in at $0 , versus $0 reported last year.